4893 items matching your search terms.

Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease

PACIFIC Study Group,

Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes

PARAGON Investigators,

Bisphosphonates for breast cancer

Pavlakis, N Stockler, M

Safety and tolerability of pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) project

Pfeffer, MA Keech, A Sacks, FM Cobbe, SM Tonkin, A Byington, RP Davis, BR Friedman, CP Braunwald, E

Safety and tolerability of Pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) project

Pfeffer, M. A. Keech, A. Sacks, F. M. Cobbe, S. M. Tonkin, A. Byington, R. P. Davis, B. R. Friedman, C. P. Braunwald, E.
CIRCULATION, 2002     DOI:10.1161/01.CIR.0000017634.00171.24

Clustering of risk factors with hypercholesterolaemia among patients with coronary heart disease in the Asia-Pacific region: the ASPAC study

Ritchie, G Zambahari, R Dans, A Yamamoto, A Keech, A
, 2002     DOI:10.1046/j.1443-9506.2003.02034.x

Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors

Sacks, FM Tonkin, AM Craven, T Pfeffer, MA Shepherd, J Keech, A Furberg, CD Braunwald, E

Coronary heart disease in patients with low LDL-cholesterol: Benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors

Sacks, F. M. Tonkin, A. M. Craven, T. Pfeffer, M. A. Shepherd, J. Keech, A. Furberg, C. D. Braunwald, E.
CIRCULATION, 2002     DOI:10.1161/01.CIR.0000012918.84068.43

Estimating risks of radiotherapy complications as part of informed consent: the high degree of variability between radiation oncologists may be related to experience

Shakespeare, TP Dwyer, M Mukherjee, R Yeghiaian-Alvandi, R Gebski, V

Lessons from the LIPID study for large-scale cholesterol-lowering trials

Simes, J.

Research plans for the LIPID samples

Simes, J.

Continuation of the FIELD study after the Heart Protection Study results

Simes, J.

International differences in patient profile, treatment and outcomes in patients with acute myocardial infarction: the HERO-2 trial, HERO-2 Satellite Symposium

Simes, J

Heart Protection Study (HPS): further results

Simes, J.

LIPID: setting the standard. 1. New evidence and insights from the extended follow-up of LIPID. 2. What can we still learn?

Simes, J.